TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8275193

Group type: EXPERIMENTAL
Intervention: Retinol, beta-carotene, and vitamin E
Number of subjects: 532

Group type: EXPERIMENTAL
Intervention: Beta-carotene (medium blood concentration)
Number of subjects: 532

Group type: EXPERIMENTAL
Intervention: Beta-carotene (high blood concentration)
Number of subjects: 532

Group type: EXPERIMENTAL
Intervention: Vitamin E (high blood concentration)
Number of subjects: 532
Study: 3755517

Group type: EXPERIMENTAL
Intervention: Vitamin D2 supplement of 1000 IU/day during the last three months of pregnancy
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Single oral dose of 5 mg at the seventh month of pregnancy
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control group (no supplementation)
Number of subjects: 77
Study: 31243706

Group type: EXPERIMENTAL
Intervention: Time series regressions using lagged inputs after treatment initiation
Number of subjects: 3657

Group type: COMPARATOR
Intervention: Baseline data only
Number of subjects: 3657

Group type: EXPERIMENTAL
Intervention: Simulated patient distributions for >50% pain score improvements
Number of subjects: 3657
Study: 29726344

Group type: COMPARATOR
Intervention: 10 Hz rTMS
Number of subjects: 414

Group type: EXPERIMENTAL
Intervention: iTBS
Number of subjects: 414
Study: 27097389

Group type: EXPERIMENTAL
Intervention: Electronic cigarette smokers (group 1)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Non-electronic cigarette smokers (group 2)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Comparison between groups at third month measurements
Number of subjects: 98
Study: 25494702

Group type: EXPERIMENTAL
Intervention: EmPhAsIS intervention (patient asthma education, SMS-based monthly adherence assessment, follow-up by pharmacists)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: EmPhAsIS intervention
Number of subjects: 0
Study: 22761527

Group type: EXPERIMENTAL
Intervention: Simulated patient case
Number of subjects: 0

Group type: COMPARATOR
Intervention: Written patient case
Number of subjects: 0
Study: 20882405

Group type: EXPERIMENTAL
Intervention: Zoledronic acid 1 mg IV weekly for 4 doses
Number of subjects: 60

Group type: COMPARATOR
Intervention: Single dose of zoledronic acid 4 mg IV
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Metronomic low‐dose zoledronic acid
Number of subjects: 60
Study: 19022840

Group type: EXPERIMENTAL
Intervention: Faecal occult blood test
Number of subjects: 106000

Group type: EXPERIMENTAL
Intervention: Screening episode
Number of subjects: 106000

Group type: EXPERIMENTAL
Intervention: Screening programme
Number of subjects: 106000

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 106000
Study: 15812609

Group type: EXPERIMENTAL
Intervention: Six-session intervention provided to the woman and her sexual partner together (n=81)
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Same intervention provided to the woman alone (n=73)
Number of subjects: 217

Group type: COMPARATOR
Intervention: One-session health information education control provided to the woman alone (n=63)
Number of subjects: 217
Study: 12419572

Group type: EXPERIMENTAL
Intervention: L-arginine (6 g)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 10489950

Group type: EXPERIMENTAL
Intervention: 20 mL bivalent intravenous scorpion antivenom
Number of subjects: 825

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 825
Study: 8598700

Group type: EXPERIMENTAL
Intervention: Filgrastim-mobilised PBPC
Number of subjects: 58

Group type: COMPARATOR
Intervention: Autologous bone marrow transplantation (ABMT)
Number of subjects: 58
Study: 2018165

Group type: EXPERIMENTAL
Intervention: Acetorphan
Number of subjects: 19

Group type: COMPARATOR
Intervention: Clonidine
Number of subjects: 19
Study: 7037524

Group type: EXPERIMENTAL
Intervention: Propylthiouracil
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study: 30385397

Group type: EXPERIMENTAL
Intervention: Topical estrogen
Number of subjects: 43

Group type: COMPARATOR
Intervention: Topical emollient
Number of subjects: 43
Study: 27097156

Group type: EXPERIMENTAL
Intervention: Ultrafiltration (UF)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Furosemide
Number of subjects: 77
Study: 27421051

Group type: EXPERIMENTAL
Intervention: Immediate ART initiation
Number of subjects: 514

Group type: COMPARATOR
Intervention: National guidelines recommended initiation (CD4≤350 cells/mm(3))
Number of subjects: 514
Study: 24045673

Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 249

Group type: COMPARATOR
Intervention: Usual activity
Number of subjects: 249
Study: 21989330

Group type: EXPERIMENTAL
Intervention: Lapatinib plus capecitabine
Number of subjects: 234

Group type: COMPARATOR
Intervention: Capecitabine
Number of subjects: 234
Study: 19509162

Group type: EXPERIMENTAL
Intervention: 10 mg oral docetaxel with ritonavir
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 100 mg oral docetaxel with ritonavir (simultaneously)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 100 mg oral docetaxel with ritonavir (60 minutes before)
Number of subjects: 12

Group type: COMPARATOR
Intervention: 100 mg i.v. docetaxel
Number of subjects: 12
Study: 17311980

Group type: EXPERIMENTAL
Intervention: Probiotics with standard antibiotic treatment
Number of subjects: 9

Group type: COMPARATOR
Intervention: Probiotics
Number of subjects: 9
Study: 15750041

Group type: EXPERIMENTAL
Intervention: Activated protein C (APC) 24 microg/kg/hour
Number of subjects: 15

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 15
Study: 12430993

Group type: EXPERIMENTAL
Intervention: Morning training
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Evening training
Number of subjects: 14

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 14
Study: 10327910

Group type: EXPERIMENTAL
Intervention: Fluvoxamine (mean daily dose 202 mg, SD = 86)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Fluvoxamine
Number of subjects: 92
Study: 7481338

Group type: EXPERIMENTAL
Intervention: Antioxidant regimen (vitamin E, vitamin C, and N-acetylcysteine)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 1683420

Group type: EXPERIMENTAL
Intervention: Sunscreen applied before UV exposure
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo applied before UV exposure
Number of subjects: 38
Study: 6980782

Group type: EXPERIMENTAL
Intervention: Specific immunotherapy with bacterial allergens (E. coli, proteus, staphylococcus, streptococcus)
Number of subjects: 1000
Study: 29624807

Group type: EXPERIMENTAL
Intervention: Meaning-centered group psychotherapy for cancer survivors (MCGP-CS)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Supportive group psychotherapy (SGP)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Care-as-usual (CAU)
Number of subjects: 170
Study: 26962728

Group type: COMPARATOR
Intervention: Sulfadoxine‐pyrimethamine (106 participants)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Three-dose dihydroartemisinin‐piperaquine (94 participants)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Monthly dihydroartemisinin‐piperaquine (100 participants)
Number of subjects: 300
Study: 24732918

Group type: EXPERIMENTAL
Intervention: 5 mg verapamil
Number of subjects: 591

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 591
Study: 22406977

Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC)
Number of subjects: 96
Study: 20696047

Group type: EXPERIMENTAL
Intervention: Intensive BP lowering to a target of 130 mmHg systolic (or by 10 mmHg if baseline systolic pressure is between 125 and 140 mmHg)
Number of subjects: 610

Group type: COMPARATOR
Intervention: Standard BP lowering to a target of 140 mmHg systolic
Number of subjects: 610

Group type: EXPERIMENTAL
Intervention: Intensive BP lowering
Number of subjects: 610

Group type: COMPARATOR
Intervention: Standard BP lowering
Number of subjects: 610
Study: 18446124

Group type: EXPERIMENTAL
Intervention: Harmonic scalpel (Group A)
Number of subjects: 101

Group type: COMPARATOR
Intervention: High-frequency electrocautery (Group B)
Number of subjects: 101
Study: 16772805

Group type: EXPERIMENTAL
Intervention: Patient-controlled thoracic epidural analgesia
Number of subjects: 120
Study: 12882706

Group type: EXPERIMENTAL
Intervention: Routine chemotherapy plus thalidomide (A)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Routine chemotherapy alone (B)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Routine chemotherapy plus thalidomide (C) for relapsing cases
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Thalidomide group
Number of subjects: 38
Study: 10999794

Group type: EXPERIMENTAL
Intervention: Alendronate 10 mg daily
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: Alendronate 5 mg daily
Number of subjects: 350

Group type: COMPARATOR
Intervention: Placebo (after 5 years of alendronate)
Number of subjects: 350
Study: 9038459

Group type: EXPERIMENTAL
Intervention: Metoclopramide 10 mg intravenously
Number of subjects: 60

Group type: COMPARATOR
Intervention: Ondansetron 8 mg intravenously
Number of subjects: 60
Study: 1792593

Group type: EXPERIMENTAL
Intervention: Theopec (TP)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Theobiolong (TB)
Number of subjects: 64
Study: 6414626

Group type: EXPERIMENTAL
Intervention: Leaflet provided to patients prescribed penicillins (56 patients)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Leaflet provided to patients prescribed non-steroidal anti-inflammatory drugs (43 patients)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Leaflet provided to patients (both groups)
Number of subjects: 99

Group type: COMPARATOR
Intervention: No leaflet provided (Control group: 65 patients prescribed penicillin and 33 prescribed non-steroidal anti-inflammatory drugs)
Number of subjects: 99
Study: 30831101

Group type: EXPERIMENTAL
Intervention: Mepivacaine 1% 10 mL intrauterine instillation
Number of subjects: 86

Group type: COMPARATOR
Intervention: 0.9% NaCl (placebo) intrauterine instillation
Number of subjects: 86
Study: 28430315

Group type: EXPERIMENTAL
Intervention: QA-based surveillance (measured quarterly using Doppler ultrasound and ultrasound dilution)
Number of subjects: 207

Group type: COMPARATOR
Intervention: Control group (surveillance based on classic alarm criteria)
Number of subjects: 207
Study: 25736569

Group type: EXPERIMENTAL
Intervention: Anodal tDCS and conventional physical therapy
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sham stimulation and conventional physical therapy
Number of subjects: 24
Study: 25749597

Group type: EXPERIMENTAL
Intervention: Mindfulness-based cancer recovery (MBCR)
Number of subjects: 271

Group type: EXPERIMENTAL
Intervention: Supportive-expressive therapy (SET)
Number of subjects: 271

Group type: COMPARATOR
Intervention: 1-day stress management seminar (SMS)
Number of subjects: 271
Study: 21883497

Group type: COMPARATOR
Intervention: Dietary manganese concentration of 0.24 mg/kg
Number of subjects: 36

Group type: COMPARATOR
Intervention: Dietary manganese concentration of 2 mg/kg
Number of subjects: 36

Group type: COMPARATOR
Intervention: Dietary manganese concentration of 4 mg/kg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Dietary manganese concentration of 16 mg/kg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Dietary manganese concentration of 32 mg/kg
Number of subjects: 36
Study: 18240114

Group type: EXPERIMENTAL
Intervention: Classical music
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Techno music
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Music for relaxation
Number of subjects: 21

Group type: COMPARATOR
Intervention: No music
Number of subjects: 21
Study: 17531542

Group type: EXPERIMENTAL
Intervention: Antiepileptic medication
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control (mild asthma)
Number of subjects: 21
Study: 15207950

Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg
Number of subjects: 116

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116
Study: 11790414

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: (-)-hydroxycitrate (HCA)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: (-)-hydroxycitrate combined with medium-chain triglycerides (HCA+MCT)
Number of subjects: 21
Study: 9710873

Group type: EXPERIMENTAL
Intervention: Submaximal all-extremity exercise test using the Pro II Power Trainer
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treadmill test
Number of subjects: 0
Study: 8035981

Group type: EXPERIMENTAL
Intervention: 3.2-mm incision
Number of subjects: 200

Group type: COMPARATOR
Intervention: 5.5-mm incision
Number of subjects: 200
Study: 3140860

Group type: EXPERIMENTAL
Intervention: FIO2 of 0.5 (50% oxygen)
Number of subjects: 35

Group type: COMPARATOR
Intervention: FIO2 of 0.33 (33% oxygen)
Number of subjects: 35
Study: 30683080

Group type: EXPERIMENTAL
Intervention: salvational intervention (SI group) with budesonide/formoterol (160μg/4.5μg once b.i.d) from the first day after severe air pollution (AQI ≥200) to the third day after AQI < 200
Number of subjects: 764

Group type: COMPARATOR
Intervention: Control group (CT group) maintaining original treatment (tiotropium and/or budesonide/formoterol)
Number of subjects: 764
Study: 28137703

Group type: EXPERIMENTAL
Intervention: Standardized EAT intervention (90 minutes of mentoring in a classroom setting)
Number of subjects: 1500

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 1500

Group type: EXPERIMENTAL
Intervention: Standardized EAT intervention
Number of subjects: 1500
Study: 26218111

Group type: EXPERIMENTAL
Intervention: Multimedia education (10-minute video on the value of CEEs)
Number of subjects: 459

Group type: COMPARATOR
Intervention: Control (no video, not retested)
Number of subjects: 459

Group type: EXPERIMENTAL
Intervention: Both groups (Intervention and Control)
Number of subjects: 459

Group type: EXPERIMENTAL
Intervention: Free CEEs offered
Number of subjects: 459
Study: 22459589

Group type: EXPERIMENTAL
Intervention: Open dismembered pyeloplasty with pelvic reduction (group A)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Pelvis-sparing pyeloplasty (group B)
Number of subjects: 40
Study: 21824709

Group type: EXPERIMENTAL
Intervention: 4000 IU of hCG (Group A)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: 6000 IU of hCG (Group B)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Both doses of u-hCG
Number of subjects: 164
Study: 19061964

Group type: EXPERIMENTAL
Intervention: Speech pathology intervention (multidimensional treatment programme including education, vocal hygiene training, cough suppression strategies, psychoeducational counseling)
Number of subjects: 87
Study: 16696745

Group type: EXPERIMENTAL
Intervention: Risedronate 30 mg once weekly for 12 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Vitamin D 400 IU daily
Number of subjects: 60
Study: 15093199

Group type: EXPERIMENTAL
Intervention: Irradiation of the whole breast delivering 50 Gy in 25 fractions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Boost of the tumor bed
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: External radiation therapy
Number of subjects: 0
Study: 11230034

Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 2045

Group type: EXPERIMENTAL
Intervention: SSRIs
Number of subjects: 2045

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2045
Study: 10198510

Group type: EXPERIMENTAL
Intervention: Pilot repeat dispensing system by community pharmacists
Number of subjects: 0
Study: 7920871

Group type: EXPERIMENTAL
Intervention: L-dopa with pyridostigmine pretreatment in obese subjects
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: L-dopa with pyridostigmine pretreatment in control subjects
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: L-dopa only in obese subjects
Number of subjects: 17

Group type: COMPARATOR
Intervention: L-dopa only in control subjects
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Pyridostigmine
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Plasma insulin and FFA levels in obese subjects
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Body mass index correlation
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: GH AUC correlation
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: FFA influence on GH AUC
Number of subjects: 17
Study: 3241870

Group type: EXPERIMENTAL
Intervention: Real beer
Number of subjects: 2

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study: 30204280

Group type: EXPERIMENTAL
Intervention: sacubitril/valsartan
Number of subjects: 1935

Group type: COMPARATOR
Intervention: enalapril
Number of subjects: 1935

Group type: EXPERIMENTAL
Intervention: baseline GDF-15
Number of subjects: 1935

Group type: EXPERIMENTAL
Intervention: changes in GDF-15
Number of subjects: 1935
Study: 27765708

Group type: EXPERIMENTAL
Intervention: New slump sitting method for lumbar spine flexion radiographs
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional method for lumbar spine flexion radiographs
Number of subjects: 60
Study: 25766947

Group type: EXPERIMENTAL
Intervention: Supervised Exercise (SE)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Stent Revascularization (ST)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Optimal Medical Care (OMC)
Number of subjects: 111
Study: 23349422

Group type: EXPERIMENTAL
Intervention: Open technique with free eruption (n = 22)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Closed technique (n = 21)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Contralateral quadrants with normally erupted canines
Number of subjects: 43
Study: 21211545

Group type: EXPERIMENTAL
Intervention: Attractive faces
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Presence of caries
Number of subjects: 263

Group type: COMPARATOR
Intervention: Unattractive faces
Number of subjects: 263

Group type: COMPARATOR
Intervention: Neither unattractive nor attractive faces
Number of subjects: 263
Study: 18462564

Group type: EXPERIMENTAL
Intervention: FSC 100/50 mcg
Number of subjects: 475

Group type: COMPARATOR
Intervention: FP 100 mcg
Number of subjects: 475
Study: 16814013

Group type: EXPERIMENTAL
Intervention: DUI court intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional court expenditures for second-time offenders
Number of subjects: 0
Study: 15748068

Group type: EXPERIMENTAL
Intervention: Home visits by trained members of the Iraqi Women's Federation during the 2-month initial phase of DOTS treatment
Number of subjects: 172

Group type: COMPARATOR
Intervention: Control group attending local health centre for treatment
Number of subjects: 172
Study: 11849851

Group type: EXPERIMENTAL
Intervention: Stent implantation with complete revascularization
Number of subjects: 1205

Group type: EXPERIMENTAL
Intervention: Stent implantation with incomplete revascularization
Number of subjects: 1205

Group type: EXPERIMENTAL
Intervention: Bypass surgery with complete revascularization
Number of subjects: 1205

Group type: EXPERIMENTAL
Intervention: Bypass surgery with incomplete revascularization
Number of subjects: 1205

Group type: COMPARATOR
Intervention: Bypass surgery
Number of subjects: 1205
Study: 9701195

Group type: EXPERIMENTAL
Intervention: Trace element supplementation (40.4 micromol Cu, 2.9 micromol Se, and 406 micromol Zn; group TE)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (20 micromol Cu, 0.4 micromol Se, and 100 micromol Zn; group C)
Number of subjects: 20
Study: 8010457

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 13

Group type: COMPARATOR
Intervention: Methohexital
Number of subjects: 13
Study: 2478849

Group type: EXPERIMENTAL
Intervention: Midwives
Number of subjects: 60

Group type: COMPARATOR
Intervention: Obstetricians
Number of subjects: 60
Study: 1034720

Group type: EXPERIMENTAL
Intervention: 10 ml of 0.25% mepivacaine
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: 10 ml of 0.25% mepivacaine containing CH3 B12 1,000 μg
Number of subjects: 230

Group type: COMPARATOR
Intervention: 10 ml of physical saline solution containing CH3 B12 1,000 μg
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: 10 ml of 0.5% procaine
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: 10 ml of 0.5% procaine containing CH3 B12 1,000 μg
Number of subjects: 230
Study: 31821667

Group type: EXPERIMENTAL
Intervention: TRAIL (simulated trail-running exercise)
Number of subjects: 11

Group type: COMPARATOR
Intervention: REST (no exercise during the day)
Number of subjects: 11
Study: 31141632

Group type: EXPERIMENTAL
Intervention: Daratumumab plus lenalidomide and dexamethasone
Number of subjects: 737

Group type: COMPARATOR
Intervention: Lenalidomide and dexamethasone alone (control group)
Number of subjects: 737
Study: 28549455

Group type: EXPERIMENTAL
Intervention: e-health driven lifestyle intervention focusing on weight, diet, physical activity, and mental well-being, including 4 coaching sessions between week 6 and month 6 postpartum and 3 coaching sessions during the new pregnancy, with the use of a mobile application connected to a weighing scale and activity tracker.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 0
Study: 24456384

Group type: EXPERIMENTAL
Intervention: Probiotic supplementation with Lactobacillus casei, Shirota strain (Yakult)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 87
Study: 23588944

Group type: EXPERIMENTAL
Intervention: Apremilast 20 mg BID
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Apremilast 40 mg QD
Number of subjects: 204

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 204
Study: 21508170

Group type: EXPERIMENTAL
Intervention: Infliximab treatment
Number of subjects: 134

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 134
Study: 19052126

Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil fumarate (DF) 300 mg once daily for 48 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Adefovir dipivoxil 10 mg once daily for 48 weeks
Number of subjects: 0
Study: 16824846

Group type: EXPERIMENTAL
Intervention: Left Ventricular (LV) pacing
Number of subjects: 74

Group type: COMPARATOR
Intervention: Biventricular (BiV) pacing
Number of subjects: 74
Study: 12612229

Group type: EXPERIMENTAL
Intervention: Cupfeeding
Number of subjects: 700

Group type: EXPERIMENTAL
Intervention: Bottle-feeding
Number of subjects: 700

Group type: EXPERIMENTAL
Intervention: Early pacifier introduction (2-5 days)
Number of subjects: 700

Group type: COMPARATOR
Intervention: Late pacifier introduction (>4 weeks)
Number of subjects: 700

Group type: EXPERIMENTAL
Intervention: Cupfeeding among cesarean delivered infants
Number of subjects: 700
Study: 10914294

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31